The classic ClinicalTrials.gov website will be retired on June 25, 2024.
Please use the modernized ClinicalTrials.gov.
For more information, see ClinicalTrials.gov Modernization.
Glossary
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Phase II single arm study testing SBRT, Adenosine signaling Modulation (AB680, AB928), and Immune Checkpoint inhibition (AB122) for men with hormone sensitive Oligometastatic prostate cancer (SBRT-AMICO)
Phase II single arm study testing SBRT, Adenosine signaling Modulation (AB680, AB928), and Immune Checkpoint inhibition (AB122) for men with hormone sensitive Oligometastatic prostate cancer (SBRT-AMICO) (1 records)